HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Guo Selected Research

Transcription Factor RelB

1/2018The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells.
6/2014[Effect of nuclear transcription factor RelB on the proteasome inhibitor-sensitivity of chronic lymphocytic leukemia cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Guo Research Topics

Disease

96Neoplasms (Cancer)
06/2022 - 06/2002
16Neoplasm Metastasis (Metastasis)
02/2022 - 11/2007
16Breast Neoplasms (Breast Cancer)
12/2021 - 09/2014
16Carcinogenesis
10/2020 - 10/2011
14Inflammation (Inflammations)
01/2022 - 08/2013
13Infections
01/2021 - 08/2005
13Acute Lung Injury
01/2020 - 07/2005
12Sepsis (Septicemia)
06/2022 - 07/2005
12Burns
09/2021 - 11/2007
11Fibrosis (Cirrhosis)
04/2022 - 01/2013
11Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 01/2017
11Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 07/2015
11Wounds and Injuries (Trauma)
09/2021 - 11/2007
10Prostatic Neoplasms (Prostate Cancer)
09/2019 - 10/2011
9Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 12/2014
9Epilepsy (Aura)
10/2021 - 01/2008
8Pancreatitis
01/2022 - 01/2017
8Stomach Neoplasms (Stomach Cancer)
12/2021 - 04/2015
7Asthma (Bronchial Asthma)
01/2022 - 01/2008
7Stroke (Strokes)
11/2021 - 09/2011
7Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2011
7Oral Submucous Fibrosis
01/2019 - 08/2011
6Ischemia
01/2022 - 06/2010
6Tremor (Tremors)
01/2021 - 12/2010
6Carcinoma (Carcinomatosis)
09/2020 - 08/2013
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2022 - 01/2022
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 08/2014
5Necrosis
10/2021 - 07/2014
5Lung Neoplasms (Lung Cancer)
07/2019 - 04/2005
5Hyperglycemia
01/2019 - 09/2015
5Infarction (Infarctions)
01/2017 - 04/2004
5Lung Injury
05/2016 - 08/2005
4Hypertension (High Blood Pressure)
01/2022 - 09/2011
4Pain (Aches)
01/2022 - 07/2012
4Wilms Tumor (Wilm's Tumor)
11/2021 - 04/2014
4Hypogonadism (Hypergonadotropic Hypogonadism)
11/2021 - 01/2019
4Pancreatic Fistula (Pancreatic Fistulas)
05/2021 - 06/2015
4Cognitive Dysfunction
01/2021 - 09/2011
4Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 04/2014
4Diabetes Mellitus
01/2020 - 01/2017
4Brain Ischemia (Cerebral Ischemia)
01/2020 - 02/2012
4Thyroid Neoplasms (Thyroid Cancer)
08/2019 - 01/2017
4Aneurysm (Aneurysms)
01/2019 - 01/2018
4Squamous Cell Carcinoma of Head and Neck
06/2016 - 08/2011
3Melanoma (Melanoma, Malignant)
12/2021 - 01/2018
3Glioma (Gliomas)
12/2021 - 12/2010
3Acute Kidney Injury (Acute Renal Failure)
11/2021 - 01/2018
3Colonic Neoplasms (Colon Cancer)
05/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2002
24Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2011
21Messenger RNA (mRNA)IBA
01/2022 - 04/2004
21MicroRNAs (MicroRNA)IBA
10/2021 - 07/2010
19Pharmaceutical PreparationsIBA
12/2021 - 10/2005
16Biological ProductsIBA
10/2021 - 06/2002
14CytokinesIBA
01/2022 - 01/2012
13Long Noncoding RNAIBA
03/2022 - 01/2018
12Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2011
10Indicators and Reagents (Reagents)IBA
01/2022 - 02/2012
9RNA (Ribonucleic Acid)IBA
01/2022 - 02/2014
8Small Interfering RNA (siRNA)IBA
12/2021 - 07/2012
7Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2022 - 01/2018
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 07/2014
7Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021 - 02/2012
7CateninsIBA
01/2019 - 01/2015
6EnzymesIBA
01/2022 - 03/2015
6NF-kappa B (NF-kB)IBA
01/2022 - 08/2009
6Triglycerides (Triacylglycerol)IBA
01/2022 - 08/2013
6Calmodulin (Calcium-Dependent Activator Protein)IBA
03/2021 - 03/2013
6Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2006
5LipidsIBA
05/2022 - 09/2011
5IntegrinsIBA
02/2022 - 07/2016
5Peptides (Polypeptides)IBA
12/2021 - 09/2005
5Cisplatin (Platino)FDA LinkGeneric
10/2021 - 04/2016
5Voltage-Gated Sodium ChannelsIBA
01/2018 - 01/2008
4SmokeIBA
01/2022 - 01/2016
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 06/2002
4CalciumIBA
01/2022 - 08/2014
4CreatinineIBA
01/2021 - 01/2017
4Therapeutic UsesIBA
01/2021 - 01/2012
4LipopolysaccharidesIBA
01/2020 - 12/2013
4HMGB1 Protein (HMG1)IBA
01/2020 - 01/2012
4UbiquitinIBA
01/2019 - 04/2015
4Glutamic Acid (Glutamate)FDA Link
01/2017 - 01/2010
4Proteasome InhibitorsIBA
07/2016 - 12/2011
4AndrogensIBA
07/2016 - 10/2011
4Tyrosine Kinase InhibitorsIBA
08/2014 - 02/2007
3Transforming Growth Factors (Transforming Growth Factor)IBA
02/2022 - 01/2017
3Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2019
3Competitive Endogenous RNAIBA
01/2022 - 01/2020
3CholesterolIBA
01/2022 - 09/2011
3Cadherins (E-Cadherin)IBA
11/2021 - 01/2017
3Testosterone (Sustanon)FDA Link
11/2021 - 04/2016
3ChromatinIBA
04/2021 - 01/2019

Therapy/Procedure

42Therapeutics
05/2022 - 07/2005
7Drug Therapy (Chemotherapy)
01/2021 - 08/2014
4Transcranial Magnetic Stimulation
09/2021 - 01/2014
4Pancreaticoduodenectomy
05/2021 - 06/2015
4Pancreatectomy
05/2021 - 01/2016
4Stents
01/2019 - 01/2018
3Length of Stay
09/2021 - 11/2020